pyrazolo(3,4-d)pyrimidine has been researched along with Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, KW; Chou, TF; Li, S; Zhang, G | 1 |
| Chandrasekaran, B; Cherukupalli, S; Chinnam, S; Hampannavar, GA; Karpoormath, R; Kayamba, F; Reddy Aleti, R; Sayyad, N | 1 |
| Chauhan, M; Kumar, R | 1 |
| Bell, RL; Buchanan, FG; Davidsen, SK; Donawho, C; Grudzien, MM; Hubbard, RD; Johnson, EF; Jung, PM; Meulbroek, JA; Pappano, WN; Sheppard, GS; Soni, NB; Wang, J; Wang, YC; Zhang, Q | 1 |
3 review(s) available for pyrazolo(3,4-d)pyrimidine and Neoplasms
| Article | Year |
|---|---|
AAA ATPases as therapeutic targets: Structure, functions, and small-molecule inhibitors.
Topics: ATPases Associated with Diverse Cellular Activities; Binding Sites; Carbazoles; Humans; Molecular Dynamics Simulation; Neoplasms; Pyrazoles; Pyrimidines; Quinazolines; Small Molecule Libraries; Zearalenone | 2021 |
An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
Topics: Adenosine; Anti-Infective Agents; Antineoplastic Agents; Cytokinins; Enzyme Inhibitors; Humans; Molecular Structure; Neoplasms; Phosphoric Diester Hydrolases; Pyrazoles; Pyrimidines | 2018 |
Medicinal attributes of pyrazolo[3,4-d]pyrimidines: a review.
Topics: Adenosine Deaminase Inhibitors; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Bacteria; Fungi; Humans; Neoplasms; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Structure-Activity Relationship; Viruses; Xanthine Oxidase | 2013 |
1 other study(ies) available for pyrazolo(3,4-d)pyrimidine and Neoplasms
| Article | Year |
|---|---|
Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Humans; Mice; Mice, Nude; Mice, SCID; Neoplasms; Oncogene Proteins; Phosphorylation; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Receptors, Somatomedin; Signal Transduction; Xenograft Model Antitumor Assays | 2009 |